Colleen F. Reitan, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 36 shares at $232.86 ($8K) on 2025-04-16, disclosed to the SEC on 2025-05-12.
Open-market sale of $8k ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |